Literature DB >> 21585647

Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs.

J Kooiman, W R van de Peppel, F J M van der Meer, M V Huisman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21585647     DOI： 10.1111/j.1538-7836.2011.04347.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  14 in total

1.  Laboratory tests during direct oral anticoagulant treatment? Yes.

Authors:  Vittorio Pengo
Journal:  Intern Emerg Med       Date:  2013-05-21       Impact factor: 3.397

2.  Renal function assessment in atrial fibrillation: Usefulness of chronic kidney disease epidemiology collaboration vs re-expressed 4 variable modification of diet in renal disease.

Authors:  Rami Riziq-Yousef Abumuaileq; Emad Abu-Assi; Andrea López-López; Sergio Raposeiras-Roubin; Moisés Rodríguez-Mañero; Luis Martínez-Sande; Francisco Javier García-Seara; Xesus Alberte Fernandez-López; Jose Ramón González-Juanatey
Journal:  World J Cardiol       Date:  2015-10-26

3.  [New oral anticoagulants for prophylaxis of stroke : Results of an expert conference on practical use in geriatric patients].

Authors:  Philipp Bahrmann; Fred Harms; Christian Martin Schambeck; Martin Wehling; Jürgen Flohr
Journal:  Z Gerontol Geriatr       Date:  2016-07       Impact factor: 1.281

4.  Oxidized Low-Density Lipoprotein Predicts the Development of Renal Dysfunction in Atrial Fibrillation.

Authors:  Marija Polovina; Ivana Petrović; Voin Brković; Milika Ašanin; Jelena Marinković; Miodrag Ostojić
Journal:  Cardiorenal Med       Date:  2016-09-16       Impact factor: 2.041

5.  The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists.

Authors:  Justyna Domienik-Karłowicz; Olga Tronina; Wojciech Lisik; Magdalena Durlik; Piotr Pruszczyk
Journal:  Cardiol J       Date:  2019-03-26       Impact factor: 2.737

Review 6.  New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures.

Authors:  Sergio Coccheri; Donatella Orlando
Journal:  Intern Emerg Med       Date:  2012-12-18       Impact factor: 3.397

Review 7.  [Anticoagulation in geriatric patients with atrial fibrillation : With what and for whom no more?]

Authors:  P Bahrmann; M Christ
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

8.  Individualising Anticoagulant Therapy in Atrial Fibrillation Patients.

Authors:  Marco Alings
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 9.  Risk of Ischemic Stroke and Stroke Prevention in Patients with Atrial Fibrillation and Renal Dysfunction.

Authors:  Tze-Fan Chao; Shih-Ann Chen
Journal:  J Atr Fibrillation       Date:  2015-06-30

10.  Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

Authors:  Judith Kooiman; Nienke van Rein; Bas Spaans; Koen A J van Beers; Jonna R Bank; Wilke R van de Peppel; Antonio Iglesias del Sol; Suzanne C Cannegieter; Ton J Rabelink; Gregory Y H Lip; Frederikus A Klok; Menno V Huisman
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.